Background: Although there is broad policy consensus that both cost containment and quality improvement are critical, the association between costs and quality is poorly understood.
A
lthough there is broad policy consensus that both cost containment and quality improvement are critical, the association between health care costs and quality is one of the more controversial topics in health policy. One possibility is that improvements in quality will require increases in cost (or conversely, cost reductions could reduce quality) (1, 2) . On the other hand, improvements in quality could lower costs by reducing complications or hospital readmissions (3) . In reality, the association between cost and quality probably falls between these 2 extremes, so that some types of health care costs are associated with high quality and others with poor quality. The effect depends on where the money is spent (4) .
The debate over the cost-quality association has been largely framed by several seminal studies that compared geographic areas in the United States. These studies documented large variations in cost across areas, with no evidence that higher-cost areas had better quality or health outcomes (5) (6) (7) (8) . Both the methods and the interpretation of these studies have been heavily debated (4, 9 -11) . The Patient Protection and Affordable Care Act mandated that the Institute of Medicine further study the issue of geographic variation in cost and quality (12) . Other studies of the cost-quality association have compared units other than geographic areas (such as hospitals) using various methods and have come to different conclusions (13, 14) . To our knowledge, there has been no previous systematic literature review of evidence on the cost-quality association in health care.
Among studies on the association between health care costs and quality, several design characteristics may be critical. First, level of analysis is important because area-level studies may yield different results than provider-or patient-level studies (4) . Second, there are many ways to measure quality, each of which may have different associations with cost (15). For example, a structural measure of quality, such as nurse staffing per patient, will probably have different cost implications than higher performance on an outcome measure, such as patient functional status. Third, "cost" can be measured in many ways, such as reimbursement from a health plan or the amount of resources used by a provider (16) . Fourth, studies may use different statistical methods, particularly in adjusting for the effects of health status on quality and costs.
To document the association between health care cost and quality and identify sources of heterogeneity between studies, we conducted a systematic review of evidence from published literature that assesses the association between health care costs and quality.
METHODS

Data Sources and Searches
We searched published literature for studies that examined the association between quality and cost or spending measures. Keywords and medical subject headings included health care costs, health spending, and quality of health care, among others. We searched PubMed, EconLit, and EMBASE databases. We also examined the bibliographies of selected studies for other potentially relevant publications and considered studies found by ad hoc searches and consultations with outside experts.
Study Selection
We included studies that empirically tested the direct association between a health care quality measure and a cost or spending measure; were published between 1 January 1990 and 10 June 2012; and focused on health care delivery at the patient, provider, or area level in the United States. We chose these criteria to exclude studies focused on the cost-benefit or cost-effectiveness of specific drugs, devices, or medical treatments (as opposed to the cost and quality of care in different delivery settings) and to ensure that the results would be generalizable to other U.S. delivery settings.
One reviewer reviewed titles and abstracts identified in the initial search for studies potentially meeting inclusion criteria. Two reviewers subsequently reviewed the full text of these studies to make final determinations of study eligibility.
Data Extraction
Two reviewers independently abstracted relevant data from the included studies using a standardized form developed for this review. All discrepancies between reviewers were resolved by consensus. Variables abstracted included unit of analysis, study population, cost measure, quality measure, control for confounders (for example, age, sex, and health status), association between cost and quality measures, and statistical methods used.
Data Synthesis and Analysis
The main study outcomes of interest were the direction, magnitude, and statistical significance of the reported association between quality and costs. Some studies compared the association between costs and quality using several types of measures. Therefore, the number of comparisons (defined as a test of the association between cost measures of a single type and quality measures of a single type) exceeded the number of studies. We analyzed reported findings of the magnitude and statistical significance of the cost-quality association for each comparison.
Comparisons were categorized as demonstrating "positive" quality-spending associations if higher cost was significantly associated with higher quality across all measures and "mixed-positive" if higher cost was significantly associated with higher quality across most, but not all, measures. Similarly, comparisons that reported that higher cost was significantly associated with lower quality were categorized as "negative" or "mixed-negative." Comparisons finding both significant positive and negative associations for different measures or analyses of the same measures were labeled "mixed." Those reporting no significant association were labeled "no difference" if the study reported a precise estimate of a zero or very small association and "imprecise or indeterminate" if the study results did not rule out the possibility of a meaningful association. To facilitate interpretation of results, we sometimes collapsed the associations into 3 groups: positive and mixed-positive findings; mixed, no difference, and imprecise or indeterminate findings; and negative and mixed-negative findings. We did not categorize studies by the magnitude of reported costquality associations; magnitudes were difficult to compare across studies because of the heterogeneity of cost and quality measures used and incomplete reporting of information needed to interpret magnitude. However, we present available information about the range of magnitudes of associations reported in included studies and provide examples of studies reporting findings with different levels of clinical significance.
Studies were categorized by 4 criteria: level of analysis, type of quality measure (several types per study were possible), type of cost measure (several types per study were possible, but we found that each reviewed study used only a single type of cost measure), and method of addressing 
Total inpatient charges (spending associated with all resource use and tallied by hospital) per Medicare admission Care intensity index 13 Fisher et al, 2003 (5) HRR-level EOL-EI ϭ hospital and physician spending during last 6 mo of life; AC-EI ϭ spending on physician and hospital services provided during the first 6 mo after index hospitalization (care intensity index) Expenditure 20 Fu and Wang, 2008 (19) Annual per capita total health expenditure including private insurance, public payers, and other sources (including out-of-pocket costs) Accounting costs confounding by health status and other factors. The level of analysis was defined as the provider (for example, hospital, nursing home, or physician), patient, or geographic area for which quality and cost or spending were measured and compared. Area-level studies typically measure the association between average health spending in the area and average quality in the area-for example, the association between average state health spending and an index of state health care quality (7) . Several studies measured spending at an area level and quality at a patient level (5, 6) ; these studies were categorized as area-level studies. For reporting purposes, we present health plan level studies in the area category in tables. Quality measures were classified into 6 categories. Five were defined by the Agency for Healthcare Research and Quality's National Quality Measures Clearinghouse (17): structure, process, outcome, patient experience, and access. The sixth category included composites of measures in 2 or more of these categories.
Cost measures were classified into 4 categories. Examples of measures in each category are provided in Table 1 . "Accounting costs" measures reflect the resources used to produce health care as measured by providers' accounting systems or estimating costs by adjusting charges using facility-or department-level cost-charge ratios from accounting systems. "Charges" measures reflect the amount that providers billed insurers for services rendered. "Expenditure" measures reflected payments for health care services by health plans, beneficiaries, or other payers. Some studies used a "care intensity index" to reflect the relative amount of resources used to produce health care services.
Lastly, studies were classified according to the methods by which they addressed confounders. A main threat to studies examining the cost-quality association is confounding by unmeasured differences in patient characteristics, particularly health status. We documented the methods that studies used to address confounding by health status and separately analyzed the subset of studies that used instrumental variables analysis (21, 22) to address confounding by unobserved differences in health status.
Role of the Funding Source
This study was funded by the Robert Wood Johnson Foundation. The funding source provided input on the scope of the study and commented on interim results but was not involved in the collection, analysis, and interpretation of the data, or in the decision to submit the manuscript for publication.
RESULTS
Search Results
The initial search resulted in 5443 citations (Figure) , 56 of which were selected for full-text review. Reference mining citations in selected studies, ad hoc searches, and expert consultations yielded 44 additional studies. Of these 100 studies, 39 were excluded because they did not empirically test the association between cost and quality or because they examined populations outside the United States. In total, 61 studies were selected for inclusion in the review. Fifteen of these studies included quality measures in several categories; however, none included cost measures in multiple categories. We separately analyzed comparisons by quality measure type. Table 2 presents the number of studies using each level of analysis and the types of cost and quality measures used in studies at each level of analysis. The included studies were widely heterogeneous in the level of analysis, cost measure, and quality measure used. There was no clear pattern of cost or quality measure used by level of analysis.
Characteristics of Included Studies
Twelve studies (20%) used area-level analysis. Among provider-level studies, hospitals were the most common level of analysis (29 studies [48%]) and nursing homes were the second most common (8 studies [13%]). Fortyone studies (67%) included outcome measures of quality, 19 studies (31%) included process measures, and other domains of quality appeared in fewer than 10 studies each. Twenty-four studies (39%) measured accounting costs, 20 studies (33%) measured expenditures, 13 studies (21%) used a care intensity index, and 4 studies (7%) measured unadjusted charges. Nine studies (15%) used instrumental variables analysis for addressing unobserved patient severity (Appendix Tables 1 to 3 , available at www.annals.org). Table 3 presents the direction of association between cost and quality documented in included studies, and the Appendix Tables include information on the sample, methods, cost and quality measures, and findings abstracted from each study. The findings of the association between health care cost and quality were inconsistent, with 21 studies (34%) reporting a positive or mixedpositive association (higher cost associated with higher quality); 18 studies (30%) reporting a negative or mixednegative association (lower cost associated with higher quality); and 22 studies (36%) reporting no difference (1 study), an imprecise or indeterminate association (8 studies), or mixed association (13 studies). However, statistical significance alone provides only a limited assessment of the evidence on the association between costs and quality.
Direction of the Association Between Costs and Quality
Magnitude of the Association Between Costs and Quality
Among studies reporting positive associations, the magnitude of the cost-quality association was typically of low to moderate clinical significance. Examples of smaller associations include a difference of 1 to 5 percentage points on process quality measures for acute myocardial infarction, congestive heart failure, and pneumonia (for example, use of a ␤-blocker at discharge for acute myocardial infarction) between hospitals in the highest and lowest quartiles of cost (13) ; a decrease in probability of mortality within 2 years of 0.0043 for each $1000 increase in the cost of a hospital stay (23) ; and 3% lower mortality (0.25 fewer deaths per 100 discharges) in hospitals at the 50th percentile versus 75th percentile of cost.
However, some studies did find larger, more clinically significant associations and many studies did not present sufficient information for interpretation of clinical significance. Examples of more clinically significant associations include an odds ratio for in-hospital mortality among patients who had an acute myocardial infarction at hospitals in the highest-versus lowest-spending quintile of 0.741 (95% CI, 0.590 to 0.891) (24), 10% greater spending over 3 years associated with a 1.5% greater survival probability (25) , and a 3.1% to 11.3% decrease in 30-day mortality (varying by condition) associated with a 10% ($2000 to $5000) increase in hospital charges per admission (18) .
Among studies with a negative association, there was also a range of magnitude. Examples of smaller associations include a 10% increase in area-level end-of-life care spending associated with a 1.003-higher relative risk for death among patients with hip fracture (CI, 0.999 to 1.006) (6); a rate of acute reperfusion that was 6 percentage points lower for patients who had an acute myocardial infarction in areas in the highest versus lowest quintile of end-of-life care spending (5); and an additional $10 000 in average hospital spending for end-of-life care associated with a decrease of 5.3 percentage points on a composite of process measures for acute myocardial infarction, pneumonia, and congestive heart failure (14) . Examples of larger associations include a difference of 15 percentage points in the proportion of physicians who felt able to obtain highquality specialist referrals between highest-and lowestspending areas (26), relative cost of trauma patients treated in hospitals with low risk-adjusted mortality rates of 0.78 (CI, 0.64 to 0.95) compared with average-mortality hospitals, and hospitals with at least 1 missed quality measure associated with 7.8% higher cost than hospitals with none missed (27) .
The results presented in many of the imprecise or indeterminate studies do not rule out the possibility of a real and clinically significant cost-quality association. For example, a study of 22 Veterans Affairs geographic networks found that an average increase of $1000 in risk-adjusted (29, 30) .
Associations by Level of Analysis
The study findings of the association between cost and quality were also inconsistent at the various levels of analysis studied. The 2 exceptions were that hospital analyses were slightly more likely to report a positive association (13 positive [45%] and 10 negative [34%]) than were studies using other levels of analysis, whereas area-level studies were more likely to report a negative association (2 positive [17%] and 5 negative [42%]).
For hospital studies, a common comparison was between cost per discharge and the in-hospital or posthospitalization mortality rate (31). Another type of common comparison was between hospital costs and process quality measures reported on the Centers for Medicare & Medicaid Services Hospital Compare Web site (13, 14, 32) . However, the type of study design did not seem to be systematically associated with the study findings.
Most area-level studies focused on comparisons between hospital referral regions (regional health care markets for tertiary care defined by the Dartmouth Atlas Project [33]), states, or counties. Some studies compared area-level mean spending and quality (7, 10) , and others tested for an association between area-level spending and quality of care for patients treated in those areas (5, 6, 34) . The results of these studies were also inconsistent, although only 2 of 12 studies (16.7%) reported a positive cost-quality association. Five studies (41.7%) reported no difference, an imprecise or indeterminate association, or a mixed association, and 5 studies (41.7%) reported a negative association.
Findings by Quality Measure Type
Most studies (41 studies [67%]) focused on an outcome measure (most commonly, a mortality measure). Comparisons between outcomes measures and cost had inconsistent findings: 17 (41.5%) resulted in a positive association with costs; 10 (24.4%) resulted in a negative association; and 14 (34.1%) resulted in no difference, an imprecise or indeterminate association, or a mixed association. Comparisons using process measures and costs also had inconsistent results. There were no systematic differences in the results of studies using underuse versus overuse process measures.
Five studies (8%) used structural measures of quality. Three studies examined correlations between spending and staffing levels in nationwide samples of nursing homes; all 3 found positive associations with cost (35-37). Two other studies showed negative associations between quality and cost (3, 38). Studies using access, patient experience, or composite measures of quality also had inconsistent findings.
Findings by Cost Measure Type
The results of the studies did not vary systematically by the type of cost measure used. Findings were mixed among the 24 studies using accounting costs, with 11 studies (45.8%) reporting a positive cost-quality association; 4 (16.7%) reporting a negative association; and 9 (37.5%) reporting no difference or mixed or indeterminate findings.
Studies that compared health expenditures and quality were similarly mixed, with 5 of 20 studies (25%) reporting positive associations, 5 (25%) reporting negative associations, and 10 (50%) with imprecise or indeterminate findings or mixed findings.
Thirteen studies compared quality with various composite measures of spending or care intensity indices. The most commonly used care intensity index was the end-oflife care expenditure index developed by the Dartmouth Atlas Project (5, 6), used in 9 studies (69%). Of these 9 studies, 5 (56%) reported a negative cost-quality association, 2 (22%) reported a positive association, and 2 (22%) had mixed findings or imprecise or indeterminate findings. This index uses a "looking-back" approach, measuring health expenditure at the end of life among a cohort of (29), hospital days and physician visits (40), and cesarean delivery (41). Two of the studies reported a positive cost-quality association, 1 reported a negative association, and 1 reported an imprecise or indeterminate association.
Methods to Address Confounding
An important methodological challenge is accounting for the effects of patient characteristics, particularly health status, which likely drives estimates of both cost and quality. No reviewed studies used experimental designs, which would account for the effects of observable and unobservable health status using randomization. Within observational studies, potential approaches for accounting for health status include natural randomization, or assignment of patients to treatment groups using a natural feature, as opposed to the controlled assignment used in randomized, controlled trials; instrumental variables analysis, which uses instrumental variables (observable factors that influence treatment but do not directly affect the outcome measure) to mimic randomization (21, 22) ; and multivariable regression analysis, which adjusts for the effects of observable health status using statistical methods but does not account for unmeasured health status. Of the 61 included studies, 9 (15%) used instrumental variables analysis to address confounding by unobserved patient health status. Seven of the 9 studies (78%) reported a positive cost-quality association and 2 had mixed findings. Forty-seven studies (77%) controlled for observable patient health risk using multivariable regression models. These studies resulted in mixed findings: 13 (28%) reported a positive cost-quality association; 18 (36%) reported a negative association; and 17 (36%) reported imprecise or indeterminate findings, no difference, or mixed findings. Two of these studies compared an "exposure" of area-level end-of-life care spending with patient-level quality measures. The authors argue that this design creates "natural randomization" of patients to spending levels, accounting for confounding by unobserved health status. The 2 studies using natural randomization reported mixed and mixed-negative associations between the end-of-life care expenditure index and quality (5, 6) . Including these 2 studies with the 9 studies using instrumental variables analysis would change the results to 7 of 11 (64%) with a positive association, 3 with mixed and 1 with mixed-negative findings.
DISCUSSION
The association between health care quality and costs has been an important consideration in policy debates on whether cuts in health care spending will negatively impact quality or whether quality improvement will decrease health care spending. Unfortunately, the published literature does not provide clear input on these important questions. Our systematic review found inconsistent evidence on both the direction and the magnitude of the association between health care costs and quality.
Most of the reviewed studies focused their discussions of findings on the direction of the association between cost and quality. However, the magnitude of the association is another important dimension of the results. Among studies with statistically significant findings, we interpreted many of the associations to be of low to moderate clinical significance. However, some studies did report clinically significant associations in both positive and negative directions, whereas others reported imprecise, non-statistically significant findings that did not preclude the possibility of a clinically significant association. Many studies did not report sufficient information for interpretation of the magnitude of the association.
The reviewed studies were very heterogeneous both in how they measure costs and quality and their level of analysis (for example, comparison of geographic areas vs. hospitals). These differences probably contributed to the inconsistency of the evidence. However, in stratified analyses, we found inconsistent evidence even among studies using similar cost measures, quality measures, and level of analysis.
Studies were also heterogeneous in methods used. Differences in methods for adjusting for health status may have contributed to inconsistency among study findings. Studies that accounted for confounding by unmeasured health status using instrumental variables analysis or other methods, such as natural randomization, were the strongest designs among reviewed studies; there were no randomized studies. Among the few studies that used instrumental variable analysis methods to address unmeasured health status, most found that higher costs were associated with better quality. However, a relatively small percentage of the studies on this topic to date have used instrumental variables analysis, and these studies differ from other included studies in other ways that may have affected their estimates of the cost-quality association.
Moving forward, several aspects of studies could be improved. Future studies should focus on what types of spending are most effective in improving quality and what types of spending represent waste. In most studies, the cost and quality measures were typically very broad without a strong conceptual linkage. For example, spending on quality improvement may result in lower spending because of fewer complications or readmissions. However, this decrease in spending is likely to be small compared with all other sources of health care spending, which are not captured by current quality measures (4) . No study disaggregated the different types of health spending or analyzed the effect of spending on different types of quality. Further, few studies broke down the association by type of patient. Certain populations may benefit more from increased resource use. Future work should also consider that the cost-quality association may be nonlinear (that is, the quality benefits of additional resources may decline and eventually become negative with increasing cost) (42, 43).
Our study has several limitations. We excluded studies from non-U.S. data sources because of concerns about generalizability. Different categorization methods for level of analysis, cost and quality measurement, or study methods could have led to different interpretations of the results. Assessing the clinical magnitude of an association and the quality of observational studies on the basis of information published was very challenging, and this review (like all systematic reviews) was limited by the quality of the original studies.
This review suggests that the association between health care cost and quality is still poorly understood. Given the immediate policy importance of this research question, additional studies are needed that more carefully disaggregate the association between health care cost and quality while addressing confounding by patient health status.
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